Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRC-PIPAC: repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy with oxaliplatin for unresectable colorectal peritoneal metastases
2017-000927-29Phase 2Active
- Sponsor
- Catharina Ziekenhuis
- Start
- Jun 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in colorectal cancer (CRC), sponsored by Catharina Ziekenhuis. Primary endpoint: Major toxicity incidence. Started Jun 2017; status: active.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2017-000927-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000927-29.